Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study
Understanding best peptides for joint pain and peptides for bone and cartilage repair expands joint-focused options
Most clinical trials focused on the common side effects like nausea, vomiting, and diarrhea
purpuratus from the barren population, likely as a stress coping mechanism related to nutrient scarcity
On the regulatory side: neither BPC-157 nor TB-500 is approved by the FDA or EMA for human use
Starting January 1, 2026 , several major insurance providers, including Blue Cross Blue Shield (BCBS), Cigna, Harvard Pilgrim, and UnitedHealthcare, will implement changes to their coverage of GLP-1 medications